Raqia Therapeutics
Alberto completed his postdoctoral training at the Harvard Medical School and the Dana-Farber Cancer Institute in the lab of Dr. Novina, prior to co-founding Raqia Therapeutics. He received his Ph.D. from the University of Greifswald (Germany).
This person is not in any offices
Raqia Therapeutics
Raqia Therapeutics is an exciting startup company developing a transformative chimeric antigen receptor (CAR) technology for immunotherapy. At Raqia Therapeutics, they are motivated to bring life-changing therapy to patients with cancer.